Using CERs to Optimize Quality of Life for Persons with Diabetes and Chronic Pain
使用 CER 优化糖尿病和慢性疼痛患者的生活质量
基本信息
- 批准号:8008653
- 负责人:
- 金额:$ 149.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2013-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Comparative effectiveness research results, such as AHRQ's Comparative Effectiveness Reviews (CER), should reach all Americans, even hard-to-reach vulnerable groups. We propose a study in the Alabama Black Belt, which includes mostly African Americans (AA), 1/3 living below the Federal poverty line and facing distance, cost and mistrust barriers to receiving healthcare services. We target a very common clinical problem in need of quality improvement: patients with chronic pain, osteoarthritis (OA) and diabetes (DM). While medication management, including CER content, is a mainstay of OA and DM therapy, biopsychosocial approaches based on cognitive-behavioral therapy (CBT) principles can improve functioning and reduce reliance on medications, which have risks for DM patients. We will examine the implementation of five CERs in clinical decision-making in the course of testing the effectiveness of a community health worker (CHW)- delivered program to improve functional status and DM metabolic parameters. To test the hypothesis that intervention group patients will have improved outcomes compared with controls, we aim to: 1: ADAPT Five CERs on OA and DM to enhance use and value in decision-making, using formative evaluation to assess needs. We will work iteratively with (1) primary care providers, to incorporate adapted materials into a state-of-the-art interactive, multimodal CME program; and (2) with Black Belt residents, to develop culturally relevant patient education materials, and incorporate them into a CHW-delivered DM-pain intervention designed to empower and activate patients, based on CBT principles. 2: TEST the CHW-delivered 16-week intervention in a group randomized trial including 400 patients with chronic pain, OA and DM. The trial will have 80% power to detect differences in functional status scores as low as 0.7, A1c >0.4%, systolic blood pressure >4 mmHg, and low density lipoprotein cholesterol >6 mg/dl (primary outcomes). Secondary outcomes include CER utilization in clinical decision-making, pain, and self- care behaviors. Providers in both arms will receive CME on the CERs. Intervention arm patients will receive the CHW empowerment intervention on pain and DM self-care with integrated CER content, and "attention" control arm patients will receive a didactic health education program without empowerment. 3: DISSEMINATE the CER products of the study through AHRQ and the UAB CME department to physicians nationally, and through the UAB School of Nursing's on-line curriculum to nurses worldwide. Dissemination products include (1) Robust evidence on whether CHWs improve CER implementation in a hard-to-reach vulnerable group; (2) On-line CME for primary care physicians and nurses on five CER topics; (3) On-line CHW training curriculum to improve health outcomes for individuals with chronic pain, OA and DM; (4) Consumer information materials tailored for southern rural AA communities on five CER topics. The trial leverages tools and infrastructure of an ongoing study and will inform policy decisions on CHWs.
PUBLIC HEALTH RELEVANCE: We propose a randomized trial to test a Community Health Worker (CHW) intervention to improve chronic pain and diabetes for patients with pain, diabetes and osteoarthritis in vulnerable, hard-to-reach patients living in Alabama's rural and impoverished Black Belt. The trial will test whether the CHW intervention has greater impact than provider education alone. In the course of the trial, we will examine how five Comparative Effectiveness Reviews can be adapted to best impact clinical decision-making to improve health outcomes.
描述(由申请人提供): 比较有效性的研究结果,如AHRQ的比较有效性审查(CER),应该达到所有美国人,甚至难以达到的弱势群体。我们建议在亚拉巴马黑带,其中包括主要是非洲裔美国人(AA),1/3生活在联邦贫困线以下,面临距离,成本和不信任的障碍,接受医疗保健服务的研究。我们的目标是一个非常常见的需要质量改进的临床问题:慢性疼痛,骨关节炎(OA)和糖尿病(DM)患者。虽然药物管理,包括CER内容,是OA和DM治疗的支柱,但基于认知行为治疗(CBT)原则的生物心理社会方法可以改善功能并减少对药物的依赖,这对DM患者有风险。我们将研究在测试社区卫生工作者(CHW)提供的改善功能状态和DM代谢参数的计划的有效性的过程中,在临床决策中实施五个CER。为了检验干预组患者与对照组相比结局改善的假设,我们的目标是:1:采用形成性评价评估需求,对OA和DM进行ADAPT五项CER,以提高决策的使用和价值。我们将与(1)初级保健提供者反复合作,将改编的材料纳入最先进的互动,多模式CME计划;(2)与黑带居民一起开发文化相关的患者教育材料,并将其纳入CHW提供的DM疼痛干预措施,旨在根据CBT原则赋予患者权力和激活患者。2:在一项包括400名慢性疼痛、OA和DM患者的分组随机试验中测试CHW提供的16周干预。该试验将有80%的把握度检测功能状态评分低至0.7,A1 c> 0.4%,收缩压>4 mmHg,低密度脂蛋白胆固醇>6 mg/dl(主要结局)的差异。次要结局包括临床决策、疼痛和自我护理行为中的CER利用率。两个部门的提供商都将收到CERs上的CME。干预组患者将接受关于疼痛和DM自我护理的CHW授权干预,并整合CER内容,“注意力”对照组患者将接受无授权的教学式健康教育计划。第三章:通过AHRQ和UAB CME部门向全国医生传播本研究的CER产品,并通过UAB护理学院的在线课程向全球护士传播。传播产品包括:(1)关于社区卫生工作者是否能改善难以接触到的弱势群体的CER实施的有力证据;(2)针对初级保健医生和护士的五个CER主题的在线继续医学教育;(3)改善慢性疼痛、OA和DM患者健康结果的在线社区卫生工作者培训课程;(4)针对南部农村AA社区的五个CER主题的消费者信息材料。该试验利用了正在进行的研究的工具和基础设施,并将为有关CHW的政策决策提供信息。
公共卫生关系:我们提出了一项随机试验,以测试社区卫生工作者(CHW)干预,以改善慢性疼痛和糖尿病患者的疼痛,糖尿病和骨关节炎在脆弱的,难以接触的患者生活在亚拉巴马的农村和贫困的黑带。该试验将测试CHW干预是否比单独提供教育具有更大的影响。在试验过程中,我们将研究如何调整五项比较有效性审查,以最大限度地影响临床决策,从而改善健康结果。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Monika M Safford其他文献
Association between overcrowded households, multigenerational households, and COVID-19: a cohort study
过度拥挤的家庭、多代家庭与 COVID-19 之间的关联:一项队列研究
- DOI:
10.1101/2021.06.14.21258904 - 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Arnab K Ghosh;Sara Venkatraman;Orysya Soroka;E. Reshetnyak;M. Rajan;A. An;John K. Chae;Christopher Gonzalez;Jonathan Prince;Charles DiMaggio;Said Ibrahim;Monika M Safford;Nathaniel Hupert - 通讯作者:
Nathaniel Hupert
Intracerebral Hemorrhage, Racial Disparities, and Access to Care.
脑出血、种族差异和获得护理的机会。
- DOI:
10.1161/circulationaha.116.024508 - 发表时间:
2016 - 期刊:
- 影响因子:37.8
- 作者:
Monika M Safford - 通讯作者:
Monika M Safford
COVID-19 ASSOCIATED DECREMENTS IN LEFT VENTRICULAR FUNCTION PREDICT MORTALITY
COVID-19 相关的左心室功能下降可预测死亡率
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:24
- 作者:
Lakshmi Nambiar;A. Volodarskiy;Arielle Kushman;Romina Tafreshi;Hannah W. Mitlak;Privthi Mohan;Sophie Mou;Evelyn M. Horn;Parag Goyal;Monika M Safford;Richard B. Devereux;J. Weinsaft;Jiwon Kim - 通讯作者:
Jiwon Kim
An Exploratory Study of Shared Decision-Making (SDM) for Older Adult Patients with Chronic Diseases
老年慢性病患者共同决策 (SDM) 的探索性研究
- DOI:
10.1145/3584931.3607023 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Yuexing Hao;Zeyu Liu;Monika M Safford;R. Tamimi;S. Kalantari - 通讯作者:
S. Kalantari
Monika M Safford的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Monika M Safford', 18)}}的其他基金
Improving Stroke Outcomes for African Americans
改善非裔美国人的中风结果
- 批准号:
8644139 - 财政年份:2014
- 资助金额:
$ 149.78万 - 项目类别:
Building Capacity for Cardiometabolic Outcomes Research
心脏代谢结果研究能力建设
- 批准号:
8383303 - 财政年份:2012
- 资助金额:
$ 149.78万 - 项目类别:
Improving Stroke Outcomes for African Americans
改善非裔美国人的中风结果
- 批准号:
8345994 - 财政年份:2012
- 资助金额:
$ 149.78万 - 项目类别:
Building Capacity for Cardiometabolic Outcomes Research
心脏代谢结果研究能力建设
- 批准号:
8656763 - 财政年份:2012
- 资助金额:
$ 149.78万 - 项目类别:
Building Capacity for Cardiometabolic Outcomes Research
心脏代谢结果研究能力建设
- 批准号:
8836577 - 财政年份:2012
- 资助金额:
$ 149.78万 - 项目类别:
Building Capacity for Cardiometabolic Outcomes Research
心脏代谢结果研究能力建设
- 批准号:
9209150 - 财政年份:2012
- 资助金额:
$ 149.78万 - 项目类别:
Building Capacity for Cardiometabolic Outcomes Research
心脏代谢结果研究能力建设
- 批准号:
8532030 - 财政年份:2012
- 资助金额:
$ 149.78万 - 项目类别:
相似国自然基金
p62/HSP27/CERS1 通路调控猪胎盘线粒体能量代谢的作用机制及干预研究
- 批准号:24ZR1434500
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
神经酰胺-TET2-CerS6正反馈回路调控小胶质细胞M1极化在心肺复苏后脑损伤中的机制研究
- 批准号:82372206
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Ang II诱导生成CerS6/C16:0参与高血压动脉硬化的机制研究
- 批准号:22ZR1452900
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
天麻素调控RAS/CerS6/eNOS通路改善血压和血管内皮功能的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Klotho抑制lncRNA NEAT1介导的miR- 23c/CerS6通路改善糖尿病肾脏病肾小管线粒体损伤的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
普洱茶茶褐素通过肠道细菌-胆汁酸作用调控肠道FXR-SPT-CerS6信号通路改善NAFLD 的作用机制
- 批准号:21ZR1448800
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
CerS6介导的线粒体神经酰胺蓄积在DKD足细胞炎症性损伤中的作用及机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CerS6调控C16:0参与血压和血管功能调节的机制研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:
基于CerS5/C16:0神经酰胺合成抑制探讨金芪降糖片遏制肝胰高血糖素反应的研究
- 批准号:82004014
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
CERS6在足细胞结构和功能稳态中的作用及其机制的研究
- 批准号:81800631
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
CerS in colon cancer: Influence on T-cells and tumor environment (B05)
结肠癌中的 CerS:对 T 细胞和肿瘤环境的影响 (B05)
- 批准号:
238121018 - 财政年份:
- 资助金额:
$ 149.78万 - 项目类别:
Collaborative Research Centres